VitrOmics is focusing on the development of, among other things, new diagnostic products based on the PamChip® technology platform. The application field is tailor-made therapy (personalized/ precision medicine). The PamChip platform was developed by VirtOmics subsidiary PamGene ( and is already used worldwide for a variety of academic and bio-pharmaceutical research applications. There is also an important link with other companies involved in personalized medicine such as Pepscan (, personalized medicines peptides and Lead Pharma (

VitrOmics sees an important role for personlized medicine in improving therapy choices for the individual patient and has initiated a number of prospective clinical studies together with care providers and health insurers.